Heart and Lung Fibrosis in a Patient with COVID-19-Related Myocarditis

J Cardiovasc Echogr. 2022 Jan-Mar;32(1):52-53. doi: 10.4103/jcecho.jcecho_43_21. Epub 2022 Apr 20.

Abstract

A COVID-19 patient, in whom pneumonia lesions were first detected by chest computed tomography, was further evaluated by cardiac magnetic resonance (CMR) due to a suspected myocarditis. Beyond heart alterations, CMR revealed peculiar features of affected pulmonary areas in T1 mapping sequences and showed a particular distribution of late gadolinium enhancement in the same regions. The noninvasive assessment of the cellular, fluid, or fibrotic content of lung lesions may provide key information about the underlying pathophysiological pathways in the search of a tailored medical therapy and ventilatory support for COVID-19 patients.

Keywords: COVID-19; Cardiac magnetic resonance; T1 mapping; interstitial pneumonia; late enhancement; myocarditis.

Publication types

  • Case Reports